Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis Journal Article


Authors: Gaudet, M. M.; Hunter, K.; Pharoah, P.; Dunning, A. M.; Driver, K.; Lissowska, J.; Sherman, M.; Peplonska, B.; Brinton, L. A.; Chanock, S.; Garcia-Closas, M.
Article Title: Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis
Abstract: Genetic variation in SIPA1, signal-induced proliferation-associated gene 1, has been proposed to be associated with aggressive breast tumor characteristics related to metastasis and worse prognosis in humans and rodents. To test this hypothesis, we genotyped 3 single nucleotide polymorphisms (SNP) located at -3092 (A<G, rs931127), exon 3-135 (C>T, rs3741378), and exon 14 1 14 (C>T, rs746429), and examined them in relation to breast cancer risk and overall survival, stratified by tumor characteristics in 2 independent case-control studies conducted in Poland (1,995 cases, 2,296 controls) and in Britain (2,142 cases, 2,257 controls). Vital status (n = 396 deaths) was available for 911 Polish and 1,919 British breast cancer cases with an average follow-up time of 5.5 years. Overall, we found no significant associations between genetic variants of SIPA1 SNPs and breast cancer risk (per allele odds ratios, 95% confidence intervals (CI): rs931127-0.99, 0.931.06; rs3741378-1.03, 0.94-1.13; and, rs74642-0.98, 0.92-1.04). In both studies, SIPA1 polymorphisms were not related to overall mortality (per allele hazard ratios, 95% CI: 1.02, 0.88-1.17; 0.90, 0.72-1.11; 1.04, 0.90-1.21, respectively). Our results do not support a relationship between SIPA1 polymorphisms and breast cancer risk or subsequent survival. © 2008 Wiley-Liss, Inc.
Keywords: cancer survival; controlled study; major clinical study; overall survival; single nucleotide polymorphism; case control study; exon; genetics; case-control studies; polymorphism, single nucleotide; mortality; cancer risk; follow up; allele; gene; tumor localization; genetic predisposition to disease; metastasis; breast cancer; tumor volume; nuclear protein; genetic variability; genotype; genetic variation; risk factors; breast neoplasms; risk factor; cancer mortality; nuclear proteins; kaplan-meiers estimate; disease severity; control group; breast tumor; guanosine triphosphatase activating protein; gtpase-activating proteins; kaplan meier method; genetic predisposition; poland; signal induced proliferation associated gene 1; tumor classification; united kingdom; vital statistics; sipa1 protein, human
Journal Title: International Journal of Cancer
Volume: 124
Issue: 7
ISSN: 0020-7136
Publisher: John Wiley & Sons  
Date Published: 2009-04-01
Start Page: 1716
End Page: 1720
Language: English
DOI: 10.1002/ijc.23919
PUBMED: 19089925
PROVIDER: scopus
PMCID: PMC2914460
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: IJCNA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mia Gaudet
    16 Gaudet